首页 | 本学科首页   官方微博 | 高级检索  
     

腺病毒载体介导的重组蛋白sTNFRII-gAD快速表达和制备
引用本文:陆月,刘丹,张孝任,刘雪荣,沈炜,郑刚,柳云帆,董小岩,吴小兵,高基民. 腺病毒载体介导的重组蛋白sTNFRII-gAD快速表达和制备[J]. 生物工程学报, 2011, 27(8): 1239-1246
作者姓名:陆月  刘丹  张孝任  刘雪荣  沈炜  郑刚  柳云帆  董小岩  吴小兵  高基民
作者单位:1. 温州医学院浙江省模式生物技术与应用重点实验室,温州325035;中国疾病预防控制中心病毒病预防控制所病毒基因工程国家重点实验室,北京100052
2. 北京五加和分子医学研究有限公司,北京,100176
3. 中国疾病预防控制中心病毒病预防控制所病毒基因工程国家重点实验室,北京,100052
4. 中国疾病预防控制中心病毒病预防控制所病毒基因工程国家重点实验室,北京100052;北京五加和分子医学研究有限公司,北京100176
5. 温州医学院浙江省模式生物技术与应用重点实验室,温州,325035
基金项目:国家新药创新重大专项 (No. 2009ZX09103-649),国家传染病重大专项 (No. 2008ZX10001-012),浙江省重大科技专项 (No. 2008C14082),浙江省自然科学基金 (No. R2080407),浙江省卫生高层次创新人才培养工程,温州市科技计划 (No. G20090142),病毒基因工程国家重点实验室开放课题,浙江省新苗计划 (No. 2009R413042) 资助。
摘    要:利用腺病毒载体高效感染哺乳动物细胞及表达外源基因的特性,建立一种快速高效表达及制备重组蛋白的方法,并用该方法获得sTNFRII-gAD (可溶性肿瘤坏死因子受体II-脂联素球部融合蛋白) 蛋白纯品。首先用携带EGFP基因的腺病毒载体rAd5-EGFP以不同的腺病毒用量 (MOI) (0~1 000) 感染BHK21c022细胞,观察比较其转导效率和细胞毒性。用AdMax腺病毒载体系统制备携带融合基因sTNFRII-gAD的重组复制缺陷型5型腺病毒rAd5-sTNFRII-gAD。用rAd5-sTNFRII-gAD以不同的MOI (0~1 000) 感染BHK21c022细胞,收取上清进行Western blotting分析,比较上清中sTNFRII-gAD蛋白的表达量。在此基础上,用rAd5-sTNFRII-gAD以MOI 100感染大量培养的BHK21c022细胞,在无血清培养条件下反复多次收取培养上清,经过硫酸铵浓缩、分子筛柱层析、透析等步骤浓缩和纯化sTNFRII-gAD融合蛋白,并体外测定该融合蛋白拮抗TNFa的活性。结果获得了携带sTNFRII-gAD融合基因的重组腺病毒rAd5-sTNFRII-gAD;用rAd5-EGFP感染BHK21c022细胞结果表明,随着腺病毒用量的增高,表达EGFP蛋白的BHK21c022细胞数量和亮度明显增加;MOI在0~100之间被感染的BHK21c022细胞未表现出明显的细胞毒性,MOI为1 000时可观察到细胞变圆和少量死亡现象。Western blotting分析结果表明,随着腺病毒用量的增高,培养上清中sTNFRII-gAD融合蛋白表达量明显增加,以MOI为1 000时最高。在此基础上,我们用MOI为100的rAd5-sTNFRII-gAD感染5个转瓶培养的BHK21c022细胞以制备sTNFRII-gAD融合蛋白。每个转瓶加无血清培养液100 mL,每48 h收获上清1次并换液,反复6次收取培养上清共约3 L,经过纯化获得了约11 mg的sTNFRII-gAD融合蛋白。体外活性测定实验表明,获得的sTNFRII-gAD融合蛋白能有效拮抗TNFα对L929细胞的杀伤作用。腺病毒载体/BHK21细胞表达系统是一个简便、高效、通用的表达系统,利用该系统成功制备了有生物学活性的sTNFRII-gAD融合蛋白。该表达系统的特点是生产规模易于放大,适应无血清培养,可以反复多次收获目标蛋白。

关 键 词:腺病毒,重组蛋白,BHK21细胞,哺乳动物细胞,sTNFRII-gAD
收稿时间:2010-12-16

Rapid expression and preparation of the recombinant fusion protein sTNFRII-gAD by adenovirus vector system
Yue Lu,Dan Liu,Xiaoren Zhang,Xuerong Liu,Wei Shen,Gang Zheng,Yunfan Liu,Xiaoyan Dong,Xiaobing Wu and Jimin Gao. Rapid expression and preparation of the recombinant fusion protein sTNFRII-gAD by adenovirus vector system[J]. Chinese journal of biotechnology, 2011, 27(8): 1239-1246
Authors:Yue Lu  Dan Liu  Xiaoren Zhang  Xuerong Liu  Wei Shen  Gang Zheng  Yunfan Liu  Xiaoyan Dong  Xiaobing Wu  Jimin Gao
Affiliation:Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, Wenzhou Medical College, Wenzhou 325035, China; National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, Wenzhou Medical College, Wenzhou 325035, China; National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, Wenzhou Medical College, Wenzhou 325035, China; National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, Wenzhou Medical College, Wenzhou 325035, China; National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;Beijing Fiveplus Molecular Medicine Institute, Beijing 100176, China;Beijing Fiveplus Molecular Medicine Institute, Beijing 100176, China;National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China; Beijing Fiveplus Molecular Medicine Institute, Beijing 100176, China;National Laboratory of Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China;Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, Wenzhou Medical College, Wenzhou 325035, China
Abstract:We expressed and prepared the recombinant fusion protein sTNFRII-gAD consisted of soluble TNF receptor II and the globular domain of adiponectin by Adenovirus Vector System in mammalian BHK21c022 cells.First we used the adenovirus vector containing EGFP gene(rAd5-EGFP) to infect BHK21c022 cells at different MOI(from 0 to 1 000),and then evaluated their transduction efficiency and cytotoxicity.Similarly,we constructed the replication-deficient adenovirus type 5-sTNFRII-gAD(rAd5-sTNFRII-gAD).We collected the ...
Keywords:adenovirus   recombinant proteins   BHK21 cells   mammalian cells   sTNFRII-gAD
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号